SmithKline Aquafresh 3Q Growth Offsets Smoking Cessation Sales Slip
This article was originally published in The Tan Sheet
Executive Summary
A 2% increase in SmithKline Beecham's oral care product sales worldwide, propelled by 9% growth in the Aquafresh line, helped the firm's consumer healthcare division maintain level third quarter sales, SB announced Oct. 31.
You may also be interested in...
GlaxoSmithKline Merger Completion Delayed To Year-End
The planned merger of SmithKline Beecham and Glaxo Wellcome will be delayed, likely until the end of the year, due to continued Federal Trade Commission inquiries.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands